[1] Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease[J]. Appl Neurophysiol, 1987, 50:344-346.
[2] Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, Daniels C, Deutschlä nder A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep brain stimulation for Parkinson's disease[J]. N Engl J Med, 2006, 355:896-908.
[3] Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, Scott R, Ives N, Rick C, Daniels J, Patel S, Wheatley K; PD SURG Collaborative Group. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial):a randomized, open-label trial[J]. Lancet Neurol, 2010, 9:581-591.
[4] Okun MS, Gallo BV, Mandybur G, Jagid J, Foote KD, Revilla FJ, Alterman R, Jankovic J, Simpson R, Junn F, Verhagen L, Arle JE, Ford B, Goodman RR, Stewart RM, Horn S, Baltuch GH, Kopell BH, Marshall F, Peichel D, Pahwa R, Lyons KE, Tröster AI, Vitek JL, Tagliati M; SJM DBS Study Group. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease:an open-label randomised controlled trial[J]. Lancet Neurol, 2012, 11:140-149.
[5] Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P, Sachse L, Steffen J, Dembek TA, Visser-Vandewalle V, Evans J, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease[J]. Mov Disord, 2018, 33:421-430.
[6] Pellaprat J, Ory-Magne F, Canivet C, Simonetta-Moreau M, Lotterie JA, Radji F, Arbus C, Gerdelat A, Chaynes P, Brefel-Courbon C. Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease[J]. Parkinsonism Relat Disord, 2014, 20:662-664.
[7] Arai E, Arai M, Uchiyama T, Higuchi Y, Aoyagi K, Yamanaka Y, Yamamoto T, Nagano O, Shiina A, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Imazeki F, Saeki N, Kuwabara S, Yokosuka O. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease[J]. Brain, 2012, 135(Pt 5):1478-1485.
[8] Dafsari HS, Petry-Schmelzer JN, Ray-Chaudhuri K, Ashkan K, Weis L, Dembek TA, Samuel M, Rizos A, Silverdale M, Barbe MT, Fink GR, Evans J, Martinez-Martin P, Antonini A, Visser-Vandewalle V, Timmermann L; EUROPAR, IPMDS Non Motor PD Study Group. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts[J]. Brain Stimul, 2018, 11:904-912.
[9] Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, Lang AE; Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep -brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease[J]. N Engl J Med, 2001, 345:956-963.
[10] Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, Beute GN, van Vugt JP, Lenders MW, Contarino MF, Mink MS, Bour LJ, van den Munckhof P, Schmand BA, de Haan RJ, Schuurman PR, de Bie RM. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study):a randomised controlled trial[J]. Lancet Neurol, 2013, 12:37-44.
[11] Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ; CSP 468 Study Group. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease[J]. N Engl J Med, 2010, 362:2077-2091.
[12] Jia F, Wagle Shukla A, Hu W, Almeida L, Holanda V, Zhang J, Meng F, Okun MS, Li L. Deep brain stimulation at variable frequency to improve motor outcomes in Parkinson's disease[J]. Mov Disord Clin Pract, 2018, 5:538-541.
[13] Wang JW, Zhang YQ, Zhang XH, Wang YP, Li JP, Li YJ. Deep brain stimulation of pedunculopontine nucleus for postural instability and gait disorder after Parkinson disease:a meta-analysis of individual patient data[J]. World Neurosurg, 2017, 102:72-78.
[14] Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hä lbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group. Neurostimulation for Parkinson's disease with early motor complications[J]. N Engl J Med, 2013, 368:610-622.
[15] Neurology Branch of Chinese Medical Association, Parkinson's Disease and Movement Disorder Group of Neurology Branch of Chinese Medical Association. Chinese expert consensus on the diagnosis of dystonia[J]. Zhonghua Shen Jing Ke Za Zhi, 2020, 53:8-12.[中华医学会神经病学分会, 中华医学会神经病学分会帕金森病及运动障碍学组. 肌张力障碍诊断中国专家共识[J]. 中华神经科杂志, 2020, 53:8-12.]
[16] Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Phenomenology and classification of dystonia:a consensus update[J]. Mov Disord, 2013, 28:863-873.
[17] Volkmann J, Wolters A, Kupsch A, Müller J, Kühn AA, Schneider GH, Poewe W, Hering S, Eisner W, Müller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Classen J, Naumann M, Benecke R; DBS study group for dystonia. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia:5-year follow-up of a randomised trial[J]. Lancet Neurol, 2012, 11:1029-1038.
[18] Volkmann J, Mueller J, Deuschl G, Kühn AA, Krauss JK, Poewe W, Timmermann L, Falk D, Kupsch A, Kivi A, Schneider GH, Schnitzler A, Südmeyer M, Voges J, Wolters A, Wittstock M, Müller JU, Hering S, Eisner W, Vesper J, Prokop T, Pinsker M, Schrader C, Kloss M, Kiening K, Boetzel K, Mehrkens J, Skogseid IM, Ramm-Pettersen J, Kemmler G, Bhatia KP, Vitek JL, Benecke R; DBS study group for dystonia. Pallidal neurostimulation in patients with medication-refractory cervical dystonia:a randomized, sham-controlled trial[J]. Lancet Neurol, 2014, 13:875-884.
[19] Gruber D, Südmeyer M, Deuschl G, Falk D, Krauss JK, Mueller J, Müller JU, Poewe W, Schneider GH, Schrader C, Vesper J, Volkmann J, Winter C, Kupsch A, Schnitzler A; DBS study group for dystonia. Neurostimulation in tardive dystonia/dyskinesia:a delayed start, sham stimulation-controlled randomized trial[J]. Brain Stimul, 2018, 11:1368-1377.
[20] Reich MM, Horn A, Lange F, Roothans J, Paschen S, Runge J, Wodarg F, Pozzi NG, Witt K, Nickl RC, Soussand L, Ewert S, Maltese V, Wittstock M, Schneider GH, Coenen V, Mahlknecht P, Poewe W, Eisner W, Helmers AK, Matthies C, Sturm V, Isaias IU, Krauss JK, Kühn AA, Deuschl G, Volkmann J. Probabilistic mapping of the antidystonic effect of pallidal neurostimulation:a multicentre imaging study[J]. Brain, 2019, 142:1386-1398.
[21] Deng Z, Pan Y, Zhang C, Zhang J, Qiu X, Zhan S, Li D, Sun B. Subthalamic deep brain stimulation in patients with primary dystonia:a ten-year follow-up study[J]. Parkinsonism Relat Disord, 2018, 55:103-110.
[22] Paschen S, Forstenpointner J, Becktepe J, Heinzel S, Hellriegel H, Witt K, Helmers AK, Deuschl G. Long-term efficacy of deep brain stimulation for essential tremor:an observer-blinded study[J]. Neurology, 2019, 92:e1378-1386.
[23] Favilla CG, Ullman D, Wagle Shukla A, Foote KD, Jacobson CE 4th, Okun MS. Worsening essential tremor following deep brain stimulation:disease progression versus tolerance[J]. Brain, 2012, 135(Pt 5):1455-1462.
[24] Reich MM, Brumberg J, Pozzi NG, Marotta G, Roothans J, Åström M, Musacchio T, Lopiano L, Lanotte M, Lehrke R, Buck AK, Volkmann J, Isaias IU. Progressive gait ataxia following deep brain stimulation for essential tremor:adverse effect or lack of efficacy[J]? Brain, 2016, 139:2948-2956.
[25] Coenen VA, Allert N, Paus S, Kronenbürger M, Urbach H, M ädler B. Modulation of the cerebello -thalamo-cortical network in thalamic deep brain stimulation for tremor:a diffusion tensor imaging study[J]. Neurosurgery, 2014, 75:657-669.
[26] Zhang JG, Ge Y, Stead M, Zhang K, Yan SS, Hu W, Meng FG. Long-term outcome of globus pallidus internus deep brain stimulation in patients with Tourette syndrome[J]. Mayo Clin Proc, 2014, 89:1506-1514.
[27] Martinez-Ramirez D, Jimenez-Shahed J, Leckman JF, Porta M, Servello D, Meng FG, Kuhn J, Huys D, Baldermann JC, Foltynie T, Hariz MI, Joyce EM, Zrinzo L, Kefalopoulou Z, Silburn P, Coyne T, Mogilner AY, Pourfar MH, Khandhar SM, Auyeung M, Ostrem JL, Visser-Vandewalle V, Welter ML, Mallet L, Karachi C, Houeto JL, Klassen BT, Ackermans L, Kaido T, Temel Y, Gross RE, Walker HC, Lozano AM, Walter BL, Mari Z, Anderson WS, Changizi BK, Moro E, Zauber SE, Schrock LE, Zhang JG, Hu W, Rizer K, Monari EH, Foote KD, Malaty IA, Deeb W, Gunduz A, Okun MS. Efficacy and safety of deep brain stimulation in Tourette syndrome:the International Tourette Syndrome Deep Brain Stimulation Public Database and Registry[J]. JAMA Neurol, 2018, 75:353-359.
[28] Welter ML, Houeto JL, Worbe Y, Diallo MH, Hartmann A, Tezenas du Montcel S, Ansquer S, Thobois S, Fontaine D, Rouaud T, Cuny E, Karachi C, Mallet L; STIC study group. Long-term effects of anterior pallidal deep brain stimulation for tourette's syndrome[J]. Mov Disord, 2019, 34:586-588.
[29] Zittel S, Tadic V, Moll CK, Bäumer T, Fellbrich A, Gulberti A, Rasche D, Brüggemann N, Tronnier V, Münchau A. Prospective evaluation of Globus pallidus internus deep brain stimulation in Huntington's disease[J]. Parkinsonism Relat Disord, 2018, 51:96-100.
[30] Wolf ME, Klockziem M, Majewski O, Schulte DM, Krauss JK, Blahak C. Implementation of new technology in patients with chronic deep brain stimulation:switching from non-rechargeable constant voltage to rechargeable constant current stimulation[J]. Stereotact Funct Neurosurg, 2019, 97:362-368.
[31] Torrecillos F, Tinkhauser G, Fischer P, Green AL, Aziz TZ, Foltynie T, Limousin P, Zrinzo L, Ashkan K, Brown P, Tan H. Modulation of beta bursts in the subthalamic nucleus predicts motor performance[J]. J Neurosci, 2018, 38:8905-8917. |